Transcat (NASDAQ: TRNS) is one of 64 public companies in the “MISC TECHNOLOGY” industry, but how does it compare to its rivals? We will compare Transcat to similar businesses based on the strength of its institutional ownership, profitability, analyst recommendations, dividends, earnings, risk and valuation.
Valuation and Earnings
This table compares Transcat and its rivals revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Transcat||$143.90 million||$4.52 million||23.01|
|Transcat Competitors||$2.21 billion||$417.03 million||40.31|
This is a summary of recent recommendations for Transcat and its rivals, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Transcat presently has a consensus target price of $20.00, indicating a potential upside of 27.80%. As a group, “MISC TECHNOLOGY” companies have a potential upside of 14.19%. Given Transcat’s stronger consensus rating and higher possible upside, research analysts clearly believe Transcat is more favorable than its rivals.
Volatility and Risk
Transcat has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, Transcat’s rivals have a beta of 0.89, meaning that their average stock price is 11% less volatile than the S&P 500.
This table compares Transcat and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Insider and Institutional Ownership
55.2% of Transcat shares are owned by institutional investors. Comparatively, 65.4% of shares of all “MISC TECHNOLOGY” companies are owned by institutional investors. 8.8% of Transcat shares are owned by company insiders. Comparatively, 9.6% of shares of all “MISC TECHNOLOGY” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Transcat rivals beat Transcat on 8 of the 13 factors compared.
Transcat Company Profile
Transcat, Inc. is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak). Through its Distribution segment, the Company markets, sells and rents national brand instruments to customers around the globe. The Company is focused on providing its services and products to the life science industries, which include pharmaceutical, biotechnology, medical device manufacturing and other Food and Drug Administration (FDA)-regulated businesses.
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.